SCHEMBL1925492

SCHEMBL1925492

NC(=O)c1[nH]cc(C(=O)O)c1-c1ccc(NC(=O)Nc2cccc(C(F)(F)F)c2F)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.53
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
CA9 Q16790 1/20 0.53
RIPK1 Q13546 2/20 0.50
KDR P35968 3/20 0.47
FLT3 P36888 3/20 0.47
KIT P10721 2/20 0.47
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
EPHX2 P34913 4/20 0.41
FABP4 P15090 1/20 0.40
IKBKB O14920 1/20 0.40
GRIK1 P39086 2/20 0.39
DGAT1 O75907 1/20 0.39
PLK4 O00444 1/20 0.39
ROCK2 O75116 1/20 0.39
MAP4K4 O95819 1/20 0.39
LCK P06239 1/20 0.39
CSF1R P07333 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1924903 0.91 KDM4E (0.47) CA12CA1CA2CA9KDR
SCHEMBL1926057 0.87 CA12 (0.48) CA12CA1CA2CA9RIPK1
SCHEMBL1925914 0.84 CA12 (0.49) CA12CA1CA2CA9RIPK1
SCHEMBL1925903 0.84 NPC1 (0.51) CA12CA1CA2CA9KDR
SCHEMBL1923695 0.83 CDK8 (0.47) RIPK1KDRFLT3KITLCK
SCHEMBL1924738 0.82 EPHX2 (0.51) CA12CA1CA2CA9KDR
SCHEMBL1923760 0.81 MEN1 (0.56) KDRFLT3KITMEN1KMT2A
SCHEMBL1924501 0.81 GRIK1 (0.44) CA12CA1CA2CA9KDR
SCHEMBL1924035 0.81 CA12 (0.53) CA12CA1CA2CA9RIPK1
SCHEMBL1926566 0.80 KDR (0.56) CA1CA2CA9RIPK1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1856043-B1 1-H-PYRROLE-2-CARBOXAMIDES AND IMIDAZOLE-5-CARBOXAMIDES AND USE THEREOF AS FAK, KDR AND TIE2 KINASE MODULATORS FOR THE TREATMENT OF CANCER AVENTIS PHARMA SA (FR) 2011-06-08 EP claimed
EP-1856043-A1 1-H-PYRROLE-2-CARBOXAMIDES AND IMIDAZOLE-5-CARBOXAMIDES AND USE THEREOF AS FAK, KDR AND TIE2 KINASE MODULATORS FOR THE TREATMENT OF CANCER Aventis Pharma S.A. (FR) 2007-11-21 EP claimed
WO-2006082309-A1 1-H-PYRROLE-2-CARBOXAMIDES AND IMIDAZOLE-5-CARBOXAMIDES AND USE THEREOF AS FAK, KDR AND TIE2 KINASE MODULATORS FOR THE TREATMENT OF CANCER AVENTIS PHARMA SA (FR) 2006-08-10 WO claimed
EP-1856043-B1 1-H-PYRROLE-2-CARBOXAMIDES AND IMIDAZOLE-5-CARBOXAMIDES AND USE THEREOF AS FAK, KDR AND TIE2 KINASE MODULATORS FOR THE TREATMENT OF CANCER AVENTIS PHARMA SA (FR) 2011-06-08 EP disclosed